50 matches for your search in the start-up spotlight
rss
We acquire, develop and license innovative drugs to treat pandemic infections. We have expanded to develop a broader portfolio of new therapies to meet the rising burden of critical priority infectious disease. Based at Alderley Park in the North West of England, our work addresses unmet patient ...
NEOGAP Therapeutics AB is a privately held clinical stage biopharmaceutical company with the main focus on immuno-oncology. The company was founded in 2016 by Dr. Hans Grönlund. We are located at Cancer Center Karolinska at Karolinska University Hospital, Solna, Sweden. Our vision is to ...
Inimmue is a new biotechnology company founded by pharmaceutical industry veterans focused on developing next generation immunotherapeutics.
HYpharm was founded in 2016 with belief and mission that the rising antibiotics crisis needs innovative solutions with bacteriophage derived proteins, the so called endolysins for use in modern medicine. The emergence of bacterial strains that are resistant to many to allmost all classes of ...
OMass Therapeutics is a private pharmaceutical company, focused on structural mass spectrometry to discover novel medicines. The company uses its suite of proprietary technologies based on high-resolution mass spectrometry to study intact protein assemblies. The technology enables detection of ...
We are an innovative German-Dutch company in the field of passive Brain-Computer Interfaces (passive BCI) and Neuroadaptive Technology to improve Human-Computer Interaction (HCI). With over fifteen years of experience delivering cutting-edge HCI, our expert scientific team led by Prof. Dr. ...
Camena Bioscience is a synthetic biology company with novel DNA synthesis technology. Built on over 7 years of innovation and with deep insight to the challenges faced in the pharmaceutical and biotechnology industries, their pioneering platform gSynth™ is rewriting the possibilities of DNA ...
Exeliom Biosciences is a clinical-stage biopharmaceutical company specialized in the development of microbiome-based immunotherapies with a mission to bring innovation to the treatment of inflammatory bowel diseases, cancer, and infectious diseases. Its lead asset, EXL01, a rationally selected, ...
Astraveus is developing the next generation of cell and gene therapy (CGT) manufacturing solutions. Astraveus's cell foundries miniaturize and automate cell and gene therapy manufacturing in a unique, modular, end-to-end, microfluidic solution that mimics the elegance of natural systems. The deep ...
TransCode is an RNA oncology company created on the belief that cancer can be effectively treated using RNA therapeutics. The Company has created a platform of drug candidates designed to target a variety of tumor types with the objective of significantly improving patient outcomes. The Company’s ...
